The MGLLblockade in tumor cells suppressed FAO pathways, leading to inhibitionof tumor growth, and the downregulation of CB-2 promoted the conversionof M2-like TAMs toward M1-like phenotypes. The gene discussed is CNR2; the disease is neoplasm.